XML 78 R17.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Warrants and Derivative Liabilities | 12 Months Ended
--- | ---
Mar. 31, 2015
Derivative Instruments And Hedging Activities Disclosure [Abstract] |
Warrants and Derivative Liabilities | 10. Warrants and Derivative Liabilities Senior Convertible Note Warrant On April 4, 2012, the Company entered into the Purchase Agreement with CVI. The Purchase Agreement included the Original Warrant to purchase 309,406 shares of the Company’s common stock. The warrant is exercisable at any time on or after the date that is six months after the issuance of the warrant and entitles CVI to purchase shares of the Company’s common stock for a period of five years from the initial date the warrant becomes exercisable at a price equal to $54.50 per share, subject to certain price-based and other anti-dilution adjustments. On October 9, 2013, the Company amended the Purchase Agreement with CVI (the “Amendment”). Pursuant to the Amendment, the Company exchanged the Original Warrant for the Exchanged Warrant, with a reduced exercise price of $26.10 per share of common stock. Other than the reduced exercise price, the Exchanged Warrant has the same terms and conditions as the Original Warrant. As a result of the sales of common stock under the ATM (See Note 12, “Stockholders’ Equity”, for further discussion of the ATM) and the 909,090 units, each unit consisting of one share of common stock and 0.90 of a warrant to purchase one share of common stock (adjusted to reflect our 1-for-10 reverse stock on March 24, 2015) sold to Hudson Bay Capital during the three months ended December 31, 2014, the exercise price of the Exchanged Warrant was reduced to $22.10 per share. The Exchanged Warrant may not be exercised if, after giving effect to the conversion, CVI together with its affiliates would beneficially own in excess of 4.99% of the Company’s common stock. This percentage may be raised to any other percentage not in excess of 9.99% at the option of CVI, upon at least 61-days prior notice to the Company, or lowered to any other percentage, at the option of CVI, at any time. The Company calculated the fair value of the derivative liabilities, (see Note 3, “Fair Value Measurements”, and Note 9, “Debt” for further discussion), and warrants utilizing an integrated lattice model. The lattice model is an option pricing model that involves the construction of a binomial tree to show the different paths that the underlying asset may take over the option’s life. A lattice model can take into account expected changes in various parameters such as volatility over the life of the options, providing more accurate estimates of option prices than the Black-Scholes model. The Company accounts for the Exchanged Warrant as a liability due to certain adjustment provisions within the warrant, which requires that it be recorded at fair value. The Exchanged Warrant is subject to revaluation at each balance sheet date and any change in fair value will be recorded as a change in fair value of derivatives and warrants until the earlier of its expiration or its exercise at which time the warrant liability will be reclassified to equity. Following is a summary of the key assumptions used to calculate the fair value of the warrant:
| March 31, |  |  | December 31, |  |  | September 30, |  |  | June 30, |  |  |  |  |  |  |  |  |
Fiscal Year 14 | 2015 |  |  | 2014 |  |  | 2014 |  |  | 2014 |  |  |  |  |  |  |  |  |
Risk-free interest rate |  | 0.73 | % |  |  | 1.00 | % |  |  | 1.07 | % |  |  | 0.98 | % |  |  |  |  |  |  |  |
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  |  |  |  |  |  |
Expected volatility |  | 70.42 | % |  |  | 72.38 | % |  |  | 76.20 | % |  |  | 83.50 | % |  |  |  |  |  |  |  |
Term (years) | 2.51 |  |  | 2.76 |  |  | 3.01 |  |  | 3.26 |  |  |  |  |  |  |  |  |
Fair value | $0.3 million |  |  | $0.5 million |  |  | $1.5 million |  |  | $2.3 million |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  | Post-modification |  |  | Pre-modification |  |  |  |  |  |  |  |  |
| March 31, |  |  | December 31, |  |  | October 9, |  |  | October 9, |  |  | September 30, |  |  | June 30, |
Fiscal Year 13 | 2014 |  |  | 2013 |  |  | 2013 |  |  | 2013 |  |  | 2013 |  |  | 2013 |
Risk-free interest rate |  | 1.11 | % |  |  | 1.17 | % |  |  | 1.05 | % |  |  | 1.05 | % |  |  | 1.02 | % |  |  | 1.13 | %
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  | — | %
Expected volatility |  | 80.99 | % |  |  | 75.60 | % |  |  | 71.45 | % |  |  | 71.45 | % |  |  | 71.98 | % |  |  | 71.90 | %
Term (years) | 3.51 |  |  | 3.76 |  |  | 3.99 |  |  | 3.99 |  |  |  | 4.01 |  |  |  | 4.27 |
Fair value | $ 2.2 million |  |  | $ 2.2 million |  |  | $ 3.2 million |  |  | $ 2.2 million |  |  | $ 2.5 million |  |  | $ 3.0 million |
| March 31, |  |  | December 31, |  |  | September 30, |  |  | June 30, |  |  | April 4, |  |  |  |  |
Fiscal Year 12 | 2013 |  |  | 2012 |  |  | 2012 |  |  | 2012 |  |  | 2012 |  |  |  |  |
Risk-free interest rate |  | 0.67 | % |  |  | 0.75 | % |  |  | 0.63 | % |  |  | 0.77 | % |  |  | 1.19 | % |  |  |  |
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  |  |
Expected volatility |  | 71.74 | % |  |  | 80.60 | % |  |  | 80.90 | % |  |  | 80.80 | % |  |  | 80.00 | % |  |  |  |
Term (years) |  | 4.51 |  |  |  | 4.76 |  |  |  | 5.01 |  |  |  | 5.28 |  |  |  | 5.50 |  |  |  |  |
Fair value | $ 3.4 million |  |  | $ 4.4 million |  |  | $ 7.1 million |  |  | $ 8.6 million |  |  | $ 7.0 million |  |  |  |  |
The Company recorded net gains, resulting from the decrease in the fair value of the Exchanged Warrant, of $1.9 million, $1.2 million and $3.6 million to change in fair value of derivatives and warrants in the years ended March 31, 2015, 2014, and 2013 respectively. Convertible Note Derivative Liability The Company determined certain embedded derivatives issued with the Initial Note required accounting as a liability, which requires they be accounted for as a standalone liability subject to revaluation at each balance sheet date with changes in fair value recorded as change in fair value of derivatives and warrants until the earlier of exercise or expiration. The terms of the December 2012 Amendment with CVI provided for, among other things, the exchange of the Initial Note for the Exchanged Note and the reduction of the conversion price of the Initial Note from $48.50 per share to $31.90 per share in the Exchanged Note. On March 2, 2014, the Company entered into an Exchange Agreement with CVI, pursuant to which the Company exchanged the Exchanged Note for approximately 663,000 shares of common stock, in full satisfaction of all amounts owed under the Exchanged Note, including any accrued interest. In addition, the Company extinguished the remaining value for the derivative liability identified with the Exchanged Note and any unamortized debt discount. Following is a summary of the key assumptions used to value the convertible notes derivative features:
| March 31, |  |  | December 31, |  |  | September 30, |  |  | June 30, |  |  |  |  |  |  |  |  |  |  |  |  |
Fiscal Year 13 | 2014 |  |  | 2013 |  |  | 2013 |  |  | 2013 |  |  |  |  |  |  |  |  |  |  |  |  |
Principal outstanding (000's) | $ — |  |  | $ | 10,411 |  |  | $ | 10,411 |  |  | $ | 14,389 |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price | N/A |  |  | $ | 16.40 |  |  | $ | 23.40 |  |  | $ | 26.40 |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage volume condition met | — % |  |  |  | 87.20 | % |  |  | 80.20 | % |  |  | 87.50 | % |  |  |  |  |  |  |  |  |  |  |  |
Expected volatility | — % |  |  |  | 68.63 | % |  |  | 66.26 | % |  |  | 65.80 | % |  |  |  |  |  |  |  |  |  |  |  |
Risk free rate | — % |  |  |  | 0.12 | % |  |  | 0.10 | % |  |  | 0.21 | % |  |  |  |  |  |  |  |  |  |  |  |
Bond yield | — % |  |  |  | 16.50 | % |  |  | 15.50 | % |  |  | 16.70 | % |  |  |  |  |  |  |  |  |  |  |  |
Recovery rate | — % |  |  |  | 35.00 | % |  |  | 35.00 | % |  |  | 37.00 | % |  |  |  |  |  |  |  |  |  |  |  |
Redeemable | N/A |  |  | yes |  |  | yes |  |  | yes |  |  |  |  |  |  |  |  |  |  |  |  |
Total time (years) | — |  |  |  | 0.75 |  |  |  | 1.00 |  |  |  | 1.26 |  |  |  |  |  |  |  |  |  |  |  |  |
Dilution effect | N/A |  |  | yes |  |  | yes |  |  | yes |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value | $ — |  |  | $ — |  |  | $ 0.2 million |  |  | $ 0.5 million |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value as a percent of par | — % |  |  |  | 0.02 | % |  |  | 0.70 | % |  |  | 3.30 | % |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  | Post-modification |  |  | Pre-modification |  |  |  |  |  |  |  |  |  |  |  |  |
| March 31, |  |  | December 31, |  |  | December 20, |  |  | December 20, |  |  | September 30, |  |  | June 30, |  |  | April 4, |
Fiscal Year 12 | 2013 |  |  | 2012 |  |  | 2012 |  |  | 2012 |  |  | 2012 |  |  | 2012 |  |  | 2012 |
Principal outstanding (000's) | $ | 15,380 |  |  | $ | 20,944 |  |  | $ | 20,944 |  |  | $ | 24,074 |  |  | $ | 24,074 |  |  | $ | 25,000 |  |  | $ | 25,000 |
Stock price | $ | 26.70 |  |  | $ | 26.20 |  |  | $ | 29.50 |  |  | $ | 29.50 |  |  | $ | 41.50 |  |  | $ | 46.80 |  |  | $ | 39.70 |
Percentage volume condition met |  | 80.50 | % |  |  | 94.50 | % |  |  | 94.90 | % |  |  | 28.60 | % |  |  | 51.00 | % |  |  | 75.20 | % |  |  | 85.90 | %
Expected volatility |  | 66.91 | % |  |  | 73.50 | % |  |  | 72.50 | % |  |  | 72.50 | % |  |  | 70.00 | % |  |  | 71.00 | % |  |  | 75.00 | %
Risk free rate |  | 0.20 | % |  |  | 0.23 | % |  |  | 0.25 | % |  |  | 0.25 | % |  |  | 0.23 | % |  |  | 0.33 | % |  |  | 0.44 | %
Bond yield |  | 16.50 | % |  |  | 16.50 | % |  |  | 16.50 | % |  |  | 16.50 | % |  |  | 15.00 | % |  |  | 16.00 | % |  |  | 15.00 | %
Recovery rate |  | 30.00 | % |  |  | 30.00 | % |  |  | 30.00 | % |  |  | 30.00 | % |  |  | 30.00 | % |  |  | 30.00 | % |  |  | 30.00 | %
Redeemable | yes |  |  | yes |  |  | yes |  |  | yes |  |  | yes |  |  | yes |  |  | yes |
Total time (years) |  | 1.51 |  |  |  | 1.76 |  |  |  | 1.79 |  |  |  | 1.79 |  |  |  | 2.01 |  |  |  | 2.28 |  |  |  | 2.50 |
Dilution effect | yes |  |  | yes |  |  | yes |  |  | yes |  |  | yes |  |  | yes |  |  | yes |
Fair value | $ 0.5 million |  |  | $ 1.0 million |  |  | $ 1.5 million |  |  | $ 0.9 million |  |  | $ 2.8 million |  |  | $ 4.5 million |  |  | $ 3.8 million |
Fair value as a percent of par |  | 3.40 | % |  |  | 4.90 | % |  |  | 7.10 | % |  |  | 3.90 | % |  |  | 11.40 | % |  |  | 17.90 | % |  |  | 15.10 | %
Based on historical VWAP of the Company’s common stock as well as the historic average dollar trading volume of the Company’s common stock, the percentage volume condition is the probability that the Company will convert monthly installment payments into the Company’s common stock. The expected volatility rate was estimated based on an equal weighting of the historical volatility of the Company’s common stock and the implied volatility of the Company’s traded options. To determine the risk-free interest rate, an interpolated rate was used based on the one, two and three-year United States Treasury rates. The bond yield was estimated using comparable corporate debt and yield information. The recovery rate of the Exchanged Note was estimated by reviewing historical corporate debt that went into default. The bond is redeemable by the Company at any point after the one-year anniversary of the grant date provided certain provisions within the note. The total time is based on the actual 30-month contractual terms. It was determined that there is a dilution effect based on the Company’s ability to make payments in shares of common stock. The Company recorded net gains, resulting from the decrease in the fair value of the derivative, of $0.5 million and $3.8 million to change in fair value of derivatives and warrants in the year ended March 31, 2014, and 2013, respectively. Senior Secured Term Loan – First Warrant On June 5, 2012, the Company entered into the Loan and Security Agreement with Hercules. (See Note 9, “Debt,” for additional information regarding the Loan and Security Agreement.) In conjunction with this agreement, the Company issued the First Warrant to purchase 13,927 shares of the Company’s common stock. The First Warrant was exercisable at any time after its issuance and had an expiration date of December 5, 2017, at a price equal to $35.90 per share subject to certain price-based and other anti-dilution adjustments. The exercise price was reduced to $19.50 per share in conjunction with entering into the New Term Loan B. An anti-dilution adjustment due to the sale of 909,090 units of the Company’s common stock to Hudson Bay Capital resulted in a reduction of the exercise price to $17.00 per share, on November 13, 2014. The Hercules Second Amendment resulted in the cancellation of the First Warrant on December 19, 2014. The Company had accounted for the First Warrant as a liability due to certain provisions within the warrant, which required that it be recorded at fair value. The First Warrant was subject to revaluation at each balance sheet date and any change in fair value was recorded as a change in fair value of derivatives and warrants until the warrant was cancelled on December 19, 2014. Following is a summary of the key assumptions used to calculate the fair value of the First Warrant:
|  |  |  |  | Pre-Exchange |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| December 31, |  |  | December 19, |  |  | September 30, |  |  | June 30, |  |  |  |  |  |  |  |  |
Fiscal Year 14 | 2014 |  |  | 2014 |  |  | 2014 |  |  | 2014 |  |  |  |  |  |  |  |  |
Risk-free interest rate |  | — | % |  |  | 1.10 | % |  |  | 1.13 | % |  |  | 1.04 | % |  |  |  |  |  |  |  |
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  |  |  |  |  |  |
Expected volatility |  | — | % |  |  | 67.01 | % |  |  | 78.30 | % |  |  | 82.75 | % |  |  |  |  |  |  |  |
Term (years) | — |  |  |  | 2.96 |  |  |  | 3.18 |  |  |  | 3.43 |  |  |  |  |  |  |  |  |
Fair value | — |  |  | $ 0.1 million |  |  | $ 0.1 million |  |  | $ 0.1 million |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  | Post-modification |  |  | Pre-modification |  |  |  |  |  |  |  |  |
| March 31, |  |  | December 31, |  |  | November 15, |  |  | November 15, |  |  | September 30, |  |  | June 30, |
Fiscal Year 13 | 2014 |  |  | 2013 |  |  | 2013 |  |  | 2013 |  |  | 2013 |  |  | 2013 |
Risk-free interest rate |  | 1.18 | % |  |  | 1.24 | % |  |  | 1.00 | % |  |  | 1.00 | % |  |  | 1.09 | % |  |  | 1.20 | %
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  | — | %
Expected volatility |  | 80.73 | % |  |  | 74.79 | % |  |  | 72.64 | % |  |  | 72.64 | % |  |  | 72.10 | % |  |  | 72.30 | %
Term (years) |  | 3.68 |  |  |  | 3.93 |  |  |  | 4.05 |  |  |  | 4.05 |  |  |  | 4.18 |  |  |  | 4.43 |
Fair value | $ 0.1 million |  |  | $ 0.1 million |  |  | $ 0.1 million |  |  | $ 0.1 million |  |  | $ 0.2 million |  |  | $ 0.2 million |
| March 31, |  |  | December 31, |  |  | September 30, |  |  | June 30, |  |  | June 5, |  |  |  |  |
Fiscal Year 12 | 2013 |  |  | 2012 |  |  | 2012 |  |  | 2012 |  |  | 2012 |  |  |  |  |
Risk-free interest rate |  | 0.70 | % |  |  | 0.75 | % |  |  | 0.64 | % |  |  | 0.80 | % |  |  | 0.77 | % |  |  |  |
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  | — | % |  |  |  |
Expected volatility |  | 72.01 | % |  |  | 80.14 | % |  |  | 81.18 | % |  |  | 80.32 | % |  |  | 79.99 | % |  |  |  |
Term (years) |  | 4.68 |  |  |  | 4.93 |  |  |  | 5.18 |  |  |  | 5.44 |  |  |  | 5.50 |  |  |  |  |
Fair value | $ 0.2 million |  |  | $ 0.2 million |  |  | $ 0.4 million |  |  | $ 0.5 million |  |  | $ 0.4 million |  |  |  |  |
The Company recorded net gains, resulting from the decrease in fair value of the First Warrant, of $0.1 million, $0.1 million and $0.2 million to change in fair value of derivatives and warrants during the years ended March 31, 2015, 2014, and 2013, respectively. Senior Secured Term Loan – Second Warrant On November 15, 2013, the Company amended the Loan and Security Agreement with Hercules and entered into the New Term Loan B. (See Note 9, “Debt,” for additional information regarding the New Term Loan B.) In conjunction with this agreement, the Company issued the Second Warrant to purchase 25,641 shares of the Company’s common stock. The Second Warrant was exercisable at any time after its issuance at a price equal to $19.50 per share subject to certain price-based and other anti-dilution adjustments and had an expiration date of May 15, 2019. An anti-dilution adjustment due to the sale of 909,090 units of the Company’s common stock to Hudson Bay Capital resulted in a reduction of the exercise price to $17.00 per share on November 13, 2014. The Hercules Second Amendment resulted in the cancellation of the Second Warrant on December 19, 2014. The Company had accounted for the Second Warrant as a liability due to certain provisions within the warrant, which required that it be recorded at fair value. The Second Warrant was subject to revaluation at each balance sheet date and any change in fair value was recorded as a change in fair value of derivatives and warrants until the warrant was cancelled on December 19, 2014. Following is a summary of the key assumptions used to calculate the fair value of the Second Warrant:
|  |  |  |  | Pre-Exchange |  |  |  |  |  |  |  |  |
| December 31, |  |  | December 19, |  |  | September 30, |  |  | June 30, |
Fiscal Year 14 | 2014 |  |  | 2014 |  |  | 2014 |  |  | 2014 |
Risk-free interest rate |  | — | % |  |  | 1.65 | % |  |  | 1.65 | % |  |  | 1.57 | %
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | % |  |  | — | %
Expected volatility |  | — | % |  |  | 71.82 | % |  |  | 78.10 | % |  |  | 80.00 | %
Term (years) | — |  |  |  | 4.41 |  |  |  | 4.62 |  |  |  | 4.87 |
Fair value | — |  |  | $0.1 million |  |  | $ 0.2 million |  |  | $ 0.3 million |
|  |  |  |  |  |  |  |  | New Issuance |  |  |  |  |
| March 31, |  |  | December 31, |  |  | November 15, |  |  |  |  |
Fiscal Year 13 | 2014 |  |  | 2013 |  |  | 2013 |  |  |  |  |
Risk-free interest rate |  | 1.76 | % |  |  | 1.89 | % |  |  | 1.55 | % |  |  |  |
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | % |  |  |  |
Expected volatility |  | 79.73 | % |  |  | 80.37 | % |  |  | 76.97 | % |  |  |  |
Term (years) |  | 5.12 |  |  |  | 5.37 |  |  |  | 5.49 |  |  |  |  |
Fair value | $ 0.3 million |  |  | $ 0.3 million |  |  | $ 0.3 million |  |  |  |  |
The Company recorded a net gain, resulting from the decrease in fair value of the Second Warrant, of $0.3 million in the year ended March 31, 2015 and no change in the year ended March 31, 2014. The Company prepared its estimates for the assumptions used to determine the fair value of the warrants issued in conjunction with both the Exchanged Note and Term Loans utilizing the respective terms of the warrants with similar inputs, as described above. Senior Secured Term Loan - New Warrant On December 19, 2014, the Company entered into the Hercules Second Amendment and entered into the New Term Loan C. (See Note 9, “Debt” for additional information regarding the New Term Loan C). In conjunction with the agreement, the Company cancelled the First and Second Warrants, and reissued a Warrant to purchase 58,823 shares of the Company’s common stock. The Warrant is exercisable at any time after its issuance at a price of $11.00 per share, subject to certain price-based and other anti-dilution adjustments, and expires on June 30, 2020. The Company accounts for the Warrant as a liability due to certain provisions within the Warrant, which requires that it be recorded at fair value. The Warrant is subject to revaluation at each balance sheet date and any change in fair value will be recorded as a change in fair value of derivatives and warrants until the earlier of its expiration or its exercise, at which time the warrant liability will be reclassified to equity. Following is a summary of the key assumptions used to calculate the fair value of the Warrant:
|  |  |  |  |  |  |  |  | New Issuance |
| March 31, |  |  | December 31, |  |  | December 19, |
Fiscal Year 14 | 2015 |  |  | 2014 |  |  | 2014 |
Risk-free interest rate |  | 1.41 | % |  |  | 1.73 | % |  |  | 1.74 | %
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | %
Expected volatility |  | 74.60 | % |  |  | 77.43 | % |  |  | 70.26 | %
Term (years) |  | 5.25 |  |  |  | 5.50 |  |  |  | 5.53 |
Fair value | $0.2 million |  |  | $0.2 million |  |  | $0.2 million |
The Company recorded no significant change in the fair value of the Warrant in the year ended March 31, 2015. November 2014 Warrant On November 13, 2014, the Company completed an offering of 909,090 units of the Company’s common stock (adjusted to reflect our 1-for-10 reverse stock split effected on March 24, 2015) with Hudson Bay Capital. (See Note 12, “Stockholder’s Equity”, for further information). Each unit consisted of one share of the Company’s common stock and 0.90 of a warrant to purchase one share of common stock, or a warrant to purchase in the aggregate 818,181 shares (the “November 2014 Warrant”). The November 2014 Warrant is exercisable at any time, at a price equal to $11.00 per share and expires on November 13, 2019. The Company accounts for the November 2014 Warrant as a liability due to certain provisions within the warrant, which requires that it be recorded at fair value. The November 2014 Warrant is subject to revaluation at each balance sheet date and any change in fair value will be recorded as a change in fair value of derivatives and warrants until the earlier of its expiration or its exercise, at which time the warrant liability will be reclassified to equity. Following is a summary of the key assumptions used to calculate the fair value of the November 2014 Warrant:
|  |  |  |  |  |  |  |  | New Issuance |
| March 31, |  |  | December 31, |  |  | November 13, |
Fiscal Year 14 | 2015 |  |  | 2014 |  |  | 2014 |
Risk-free interest rate |  | 1.28 | % |  |  | 1.61 | % |  |  | 1.64 | %
Expected annual dividend yield |  | — | % |  |  | — | % |  |  | — | %
Expected volatility |  | 75.96 | % |  |  | 78.00 | % |  |  | 72.86 | %
Term (years) |  | 4.62 |  |  |  | 4.87 |  |  |  | 5.00 |
Fair value | $2.5 million |  |  | $3.2 million |  |  | $4.3 million |
The Company recorded a decrease in the fair value of the November 2014 Warrant, resulting in a gain of $1.8 million in the year ended March 31, 2015.

X
- Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5618551-113959 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5708775-113959 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 25 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4E -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624181-113959 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4H -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624258-113959 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624163-113959 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(n)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5708773-113959 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4D -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624177-113959 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41620-113959 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5579245-113959 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5580258-113959 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5579240-113959 Reference 17: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41641-113959 Reference 18: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41638-113959 Reference 19: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration